SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cemtrex, Inc. engages in the provision of solutions in the technology industry. It operates through the following segments: Security, Industrial Services, and Cemtrex Corporate. The Security segment provides end-to-end security solutions to meet corporate, industrial, and governmental security challenges. The Industrial Services segment offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. The Cemtrex Corporate segment refers to the holding company of the other two segments. The company was founded on April 27, 1998 and is headquartered in Hauppauge, NY.

Cemtrex Inc.

Cemtrex ($CETX) is trending due to high volatility and speculation around a potential short squeeze, fueled by a massive surge in volume and borrow rates. The community is actively debating entry points, potential price targets, and whether the stock can replicate the moves of other recent high-flying, low-float stocks. Some traders cite the company's small market cap and high revenue as reasons for optimism.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid a potential bidding war for Warner Bros. Discovery, with Paramount making a competing offer and raising questions about regulatory hurdles. The community is debating the merits of the deal, potential impacts on Netflix's financials, and the influence of political factors on the outcome. Investors are weighing whether Netflix should pursue the acquisition or focus on organic growth.

AlphaTime Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on September 15, 2021 and is headquartered in New York, NY.

AlphaTime Acquisition Corp

AlphaTime Acquisition Corp ($ATMC) is trending due to significant after-hours volatility, with community members citing its status as a recently merged SPAC with a low float as a potential catalyst for a large price swing. Some traders are pointing to similarities with other low-float runners and anticipating a substantial move, while others are expressing skepticism and cautioning against potential risks associated with the stock's rapid price increase.

SAIHEAT Ltd. engages in the operation of cryptocurrency mining. It operates Bitcoin for its own account and provides full suite of services, purchase of mining machines, hosting service, and mining pool. The company was founded by Risheng Li on February 2, 2021, and is headquartered in Singapore.

SAIHEAT Ltd. - Ordinary Shares - Class A

SAIHEAT Ltd

SAIH is trending due to increasing interest in its low float and potential for a short squeeze, with traders drawing comparisons to other recent high-flying stocks like TWG and XCUR; some are attributing momentum to news around nuclear and SMR (small modular reactor) technology, and potential ties to Amazon data center initiatives, fueling speculation for a significant price surge.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences ($WVE) is trending due to a significant surge following positive Phase 1 data for its obesity drug, WVE-007; however, some investors are wary of a potential offering. The community is actively debating the stock's future, with some anticipating further gains while others predict a pullback. Discussions also involve the drug's potential to disrupt the weight-loss market and competition with GLP-1 therapies.

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Redwood City, CA.

Exicure Inc

XCUR is trending after reporting positive Phase 2 trial results for its drug burixafor in multiple myeloma patients, showing high success in stem cell mobilization. The community is discussing the potential for secondary share offerings and comparing the stock's potential to previous runners. Some traders are focusing on the small float and speculating on a possible short squeeze, while others note the company's need for additional financing.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is trending amid reports of Paramount launching a hostile all-cash takeover bid at $30 per share, challenging Netflix's existing offer and sparking debate about the best path forward. Community discussions revolve around the potential for a bidding war and the deal's implications for the streaming landscape, with some seeing Paramount's offer as a superior deal for shareholders.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending as investors eagerly await 48-week data for Pemvidutide, with speculation building around potential FDA feedback and breakthrough therapy designation. The community is buzzing about the possibility of the data confirming Pemvidutide's best-in-class potential for MASH treatment, particularly regarding statistically significant fibrosis improvement and weight loss. Discussions also involve potential buyout scenarios and comparisons to other companies in the MASH and weight loss space.

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Structure Therapeutics Inc - ADR

GPCR is trending due to speculation around potential acquisition following positive clinical trial data for its oral GLP-1 candidate, aleniglipron; community discussions revolve around its efficacy and safety profile compared to competitors, particularly in light of recent developments in the obesity drug market and concerns about liver toxicity. Some traders are noting the potential for a secondary offering soon. There are also buyout rumors, with some saying NVO may make a bid.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance (PSKY) is trending amidst a bidding war for Warner Bros. Discovery, with PSKY launching an all-cash tender offer. Community discussions revolve around whether WBD will accept PSKY's offer or a deal with Netflix, and potential regulatory hurdles. The involvement of sovereign wealth funds and political figures adds complexity to the situation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Best Chinese Stocks To Research - December 5th

Diageo, UP Fintech, Regencell Bioscience, RBB Bancorp, Universe Pharmaceuticals, Taoping, and BGM Group are the seven Chinese stocks to watch today, according to MarketBeat's stock screener tool...

Chinese Stocks To Consider - December 6th

Diageo, UP Fintech, Regencell Bioscience, RBB Bancorp, Hf Foods Group, Universe Pharmaceuticals, and Taoping are the seven Chinese stocks to watch today, according to MarketBeat's stock screener...

Chinese Stocks To Follow Today - December 4th

Diageo, UP Fintech, Regencell Bioscience, Universe Pharmaceuticals, Taoping, RBB Bancorp, and Baiya International Group are the seven Chinese stocks to watch today, according to MarketBeat's stock...

Top Chinese Stocks To Watch Now - December 3rd

Diageo, UP Fintech, Regencell Bioscience, Taoping, RBB Bancorp, Baiya International Group, and China SXT Pharmaceuticals are the seven Chinese stocks to watch today, according to MarketBeat's stock...

Taoping Signs Letter of Intent to Acquire Alphalion Holding, Significantly Bolsters AI-Driven Digital Ecosystem

Taoping Signs Letter of Intent to Acquire Alphalion Holding, Significantly Bolsters AI-Driven Digital Ecosystem Taoping Signs Letter of Intent to Acquire Alphalion Holding, Significantly Bolsters...

Taoping Announces Major Cooperation with the Mengla County of Yunan Province; Expected Project Value of US$82.5 Million by 2027

Taoping Announces Major Cooperation with the Mengla County of Yunan Province; Expected Project Value of US$82.5 Million by 2027 Taoping Announces Major Cooperation with the Mengla County of Yunan...

Taoping Signs Non-binding Letter of Intent to Acquire Yunti; Transformational Acquisition Would Substantially Improve Taoping's Annual Revenue, Expand its Addressable Market, and Leverage its Current Portfolio

Taoping Signs Non-binding Letter of Intent to Acquire Yunti; Transformational Acquisition Would Substantially Improve Taoping's Annual Revenue, Expand its Addressable Market, and Leverage its Current...

Taoping Reports 28.4% Increase in Revenue for the First Six Months of 2024, with EPS of $0.13 Per Diluted Share Compared to a Loss of $1.10 in the Corresponding Period of 2023

Taoping Reports 28.4% Increase in Revenue for the First Six Months of 2024, with EPS of $0.13 Per Diluted Share Compared to a Loss of $1.10 in the Corresponding Period of 2023 Taoping Reports 28.4...

Alert: 30% YoY Growth in Taoping's July 2024 Total Contract Revenue Value Driven by Strong Demand for AI-Based Products

Alert: 30% YoY Growth in Taoping's July 2024 Total Contract Revenue Value Driven by Strong Demand for AI-Based Products Alert: 30% YoY Growth in Taoping's July 2024 Total Contract Revenue Value...

Taoping Accelerates AI Business Growth with New Order for AI-Powered Smart Terminals

Taoping Accelerates AI Business Growth with New Order for AI-Powered Smart Terminals Taoping Accelerates AI Business Growth with New Order for AI-Powered Smart Terminals PR Newswire SHENZHEN, China...

Taoping, Inc. operates as block chain technology and smart cloud services provider. It operates through the following segments: Cloud-based Technology, Blockchain Technology, Traditional Information Technology. The CBT segment includes the company's cloud based products and data storage related services sold to private sectors. The BT segment is the company's Crypto currency mining initiative. The TIT segment is involved in the company's project-based technology products and services sold to the public sector such as Geographic Information System, Digital Public Security Technology, and Digital Hospital Information Systems. The company was founded in 1993 and is headquartered in Hong Kong.

TAOP
Taoping Inc.

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest TAOP News

TAOPTaoping Inc.